EP2788001
NASAL FORMULATION
:
EP einkaleyfi: Þýðing ekki lögð inn:
4.12.2012:
2.12.2015:
12797884.9
:
3.12.2032
:
NASAL FORMULATION
4.12.2012
2.12.2015
:
Teva Branded Pharmaceutical Products R & D, Inc.:
41 Moores Road, 19355, Frazer, Pennsylvania, US
:
ZENG, Xian-Ming:
Miami, Florida, US
:
LY, Jade Ching-Ying:
Miami, Florida, US
:
DALVI, Mukul C:
Miami, Florida, US
:
201161567893 P:
7.12.2011:
US
:
201121812:
19.12.2011:
GB
:
WO2013083569:
4.12.2012
:
A61K 31/55, A61K 31/573, A61K 9/00, A61K 9/12, A61M 11/04, A61M 11/06, A61M 15/00, A61M 15/08, A61P 27/14